Vaccine maker Novavax stock jumped double digits on Thursday after the company reported its quarterly sales had more than ...

The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...

The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its ...

Agency commissioner Dr. Marty Makary announced Tuesday that Dr. Vinay Prasad, a prominent COVID-19 vaccine critic, has been ...

The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Kennedy Jr. has minimized the risk COVID-19 poses to kids and exaggerated the risk of the vaccine, incorrectly claiming that the shot poses a “profound risk” to children. While serious side ...

A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...

Trinity College Dublin researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended ...

Memoli, who gained attention in 2021 for opposing Covid-19 vaccine mandates and reportedly declined Covid-19 vaccination himself, said in 2022 that one of the vaccines being advanced in this ...